Proteomic strategy for probing complementary lethality of kinase inhibitors against pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Proteomic strategy for probing complementary lethality of kinase inhibitors against pancreatic cancer

Published:2013-11-25 Issue:23-24 Volume:13 Page:3554-3562
ISSN:1615-9853
Container-title:PROTEOMICS
language:en
Short-container-title:Proteomics

Author:

Lee Jin-Gyun¹,McKinney Kimberly Q.¹,Mougeot Jean-Luc²,Bonkovsky Herbert L.²³,Hwang Sun-Il¹²

Affiliation:

1. Proteomics and Mass Spectrometry Research Laboratory; Carolinas HealthCare System; Charlotte NC USA

2. Department of Therapeutic Research and Development; Carolinas HealthCare System; Charlotte NC USA

3. Department of Medicine; Carolinas HealthCare System; Charlotte NC USA

Funder

Carolinas HealthCare System, Cannon Research Grant

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pmic.201300248/fullpdf

Reference42 articles.

1. Pancreatic cancer: a review and update;Dunphy;Clin. J. Oncol. Nurs.,2008

2. Pancreatic cancer: a review of recent advances;Eckel;Expert Opin. Investig. Drugs,2006

3. Metastatic pancreatic cancer response to treatment with cetuximab and gemcitabine plus capecitabine: a case report and review of the literature;Li;Tumori,2010

4. Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? (Review);di Marco;Oncol. Rep.,2010

5. Phenotype and genotype of pancreatic cancer cell lines;Deer;Pancreas,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antisense transcription and its roles in adaption to environmental stress inE. coli;2023-03-24

2. Predictive and prognostic effect of HO-1 expression in breast cancer patients undergoing neoadjuvant chemotherapy;Breast Cancer Research and Treatment;2022-03-18

3. HO-1/CO system in tumor growth, angiogenesis and metabolism — Targeting HO-1 as an anti-tumor therapy;Vascular Pharmacology;2015-11

4. Src/ STAT 3‐dependent heme oxygenase‐1 induction mediates chemoresistance of breast cancer cells to doxorubicin by promoting autophagy;Cancer Science;2015-07-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3